To investigated the benefit of clinical implantation of L-FABP, further studies might be needed to investigate whether early detection and prediction of AKI by urinary L-FABP, combined with AKI management protocol, based on KDIGO guidelines, can improve the outcomes of patients after cardiovascular surgery. This evidence concerns the gene FABP1 and acute kidney injury.